Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048231804> ?p ?o ?g. }
- W3048231804 endingPage "105735" @default.
- W3048231804 startingPage "105735" @default.
- W3048231804 abstract "Despite advances in breast cancer (BC) treatment, its mortality remains high due to intrinsic or acquired resistance to therapy. Several ongoing efforts are being made to develop novel drugs to treat this pathology with the aim to overcome resistance, prolong patient survival and improve their quality of life. We have previously shown that the non-hypercalcemic vitamin D analogues EM1 and UVB1 display antitumor effects in preclinical studies employing conventional cell lines and animal models developed from these cells. In this work, we explored the antitumor effects of EM1 and UVB1 employing BC cells derived from patient-derived xenografts (PDXs), which are a powerful preclinical tool for testing new drugs. We demonstrated that the analogues reduced the viability of HER2-positive and Triple Negative BC-PDXs. Moreover, using an in vitro model of acquired resistance to Trastuzumab-emtansine, UVB1 displayed anti-proliferative actions under 2D and 3D culture conditions. It inhibited both formation and growth of established organoids. In addition, a direct correlation between UVB1 antitumor effects and VDR expression in PDXs was found. In conclusion, all the results reinforce the potential use of these vitamin D analogues as antitumor agents to treat HER2-positive and Triple Negative BC." @default.
- W3048231804 created "2020-08-13" @default.
- W3048231804 creator A5014248500 @default.
- W3048231804 creator A5019658762 @default.
- W3048231804 creator A5024268025 @default.
- W3048231804 creator A5024277563 @default.
- W3048231804 creator A5026139001 @default.
- W3048231804 creator A5041386436 @default.
- W3048231804 creator A5044407052 @default.
- W3048231804 creator A5048038667 @default.
- W3048231804 creator A5052358211 @default.
- W3048231804 creator A5071273165 @default.
- W3048231804 creator A5077169627 @default.
- W3048231804 creator A5081518200 @default.
- W3048231804 creator A5089031414 @default.
- W3048231804 date "2021-04-01" @default.
- W3048231804 modified "2023-10-18" @default.
- W3048231804 title "Vitamin D analogues exhibit antineoplastic activity in breast cancer patient-derived xenograft cells" @default.
- W3048231804 cites W1472101725 @default.
- W3048231804 cites W1852205543 @default.
- W3048231804 cites W1943126952 @default.
- W3048231804 cites W1965890948 @default.
- W3048231804 cites W2009164582 @default.
- W3048231804 cites W2021550972 @default.
- W3048231804 cites W2043028214 @default.
- W3048231804 cites W2046085802 @default.
- W3048231804 cites W2145369521 @default.
- W3048231804 cites W2297967082 @default.
- W3048231804 cites W2312939933 @default.
- W3048231804 cites W2398165087 @default.
- W3048231804 cites W2466026863 @default.
- W3048231804 cites W2498228861 @default.
- W3048231804 cites W2523763608 @default.
- W3048231804 cites W2564066883 @default.
- W3048231804 cites W2574695762 @default.
- W3048231804 cites W2590130519 @default.
- W3048231804 cites W2595081519 @default.
- W3048231804 cites W2737334140 @default.
- W3048231804 cites W2766742812 @default.
- W3048231804 cites W2781370437 @default.
- W3048231804 cites W2889646458 @default.
- W3048231804 cites W2981470718 @default.
- W3048231804 cites W3001369781 @default.
- W3048231804 cites W3006656146 @default.
- W3048231804 cites W3011656223 @default.
- W3048231804 cites W3013445138 @default.
- W3048231804 cites W3016050307 @default.
- W3048231804 doi "https://doi.org/10.1016/j.jsbmb.2020.105735" @default.
- W3048231804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32784045" @default.
- W3048231804 hasPublicationYear "2021" @default.
- W3048231804 type Work @default.
- W3048231804 sameAs 3048231804 @default.
- W3048231804 citedByCount "8" @default.
- W3048231804 countsByYear W30482318042021 @default.
- W3048231804 countsByYear W30482318042022 @default.
- W3048231804 countsByYear W30482318042023 @default.
- W3048231804 crossrefType "journal-article" @default.
- W3048231804 hasAuthorship W3048231804A5014248500 @default.
- W3048231804 hasAuthorship W3048231804A5019658762 @default.
- W3048231804 hasAuthorship W3048231804A5024268025 @default.
- W3048231804 hasAuthorship W3048231804A5024277563 @default.
- W3048231804 hasAuthorship W3048231804A5026139001 @default.
- W3048231804 hasAuthorship W3048231804A5041386436 @default.
- W3048231804 hasAuthorship W3048231804A5044407052 @default.
- W3048231804 hasAuthorship W3048231804A5048038667 @default.
- W3048231804 hasAuthorship W3048231804A5052358211 @default.
- W3048231804 hasAuthorship W3048231804A5071273165 @default.
- W3048231804 hasAuthorship W3048231804A5077169627 @default.
- W3048231804 hasAuthorship W3048231804A5081518200 @default.
- W3048231804 hasAuthorship W3048231804A5089031414 @default.
- W3048231804 hasBestOaLocation W30482318042 @default.
- W3048231804 hasConcept C121608353 @default.
- W3048231804 hasConcept C124490489 @default.
- W3048231804 hasConcept C126322002 @default.
- W3048231804 hasConcept C179639408 @default.
- W3048231804 hasConcept C2778087150 @default.
- W3048231804 hasConcept C2779786085 @default.
- W3048231804 hasConcept C2780110267 @default.
- W3048231804 hasConcept C502942594 @default.
- W3048231804 hasConcept C530470458 @default.
- W3048231804 hasConcept C71924100 @default.
- W3048231804 hasConcept C98274493 @default.
- W3048231804 hasConceptScore W3048231804C121608353 @default.
- W3048231804 hasConceptScore W3048231804C124490489 @default.
- W3048231804 hasConceptScore W3048231804C126322002 @default.
- W3048231804 hasConceptScore W3048231804C179639408 @default.
- W3048231804 hasConceptScore W3048231804C2778087150 @default.
- W3048231804 hasConceptScore W3048231804C2779786085 @default.
- W3048231804 hasConceptScore W3048231804C2780110267 @default.
- W3048231804 hasConceptScore W3048231804C502942594 @default.
- W3048231804 hasConceptScore W3048231804C530470458 @default.
- W3048231804 hasConceptScore W3048231804C71924100 @default.
- W3048231804 hasConceptScore W3048231804C98274493 @default.
- W3048231804 hasFunder F4320306260 @default.
- W3048231804 hasFunder F4320321594 @default.
- W3048231804 hasFunder F4320334832 @default.
- W3048231804 hasFunder F4320334923 @default.
- W3048231804 hasFunder F4320335321 @default.